• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

比较由霍乱弧菌O139孟加拉型引起的霍乱与由霍乱弧菌O1引起的霍乱中杀弧菌抗体反应。

Comparison of the vibriocidal antibody response in cholera due to Vibrio cholerae O139 Bengal with the response in cholera due to Vibrio cholerae O1.

作者信息

Qadri F, Mohi G, Hossain J, Azim T, Khan A M, Salam M A, Sack R B, Albert M J, Svennerholm A M

机构信息

International Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka, fqadri%

出版信息

Clin Diagn Lab Immunol. 1995 Nov;2(6):685-8. doi: 10.1128/cdli.2.6.685-688.1995.

DOI:10.1128/cdli.2.6.685-688.1995
PMID:8574829
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC170220/
Abstract

Vibrio cholerae serogroup O139, now considered to be the second organism capable of causing epidemic severe dehydrating cholera, contains a capsular polysaccharide which makes it difficult for it to be used in the conventional vibriocidal antibody assay optimized for V. cholerae O1. After modification of the procedure, which involved the use of specific bacterial strains, a lower bacterial inoculum, and increased amounts of complement, the vibriocidal antibody responses to V. cholerae O139 were measured in acute- and convalescent-phase sera from 33 V. cholerae O139-infected and 18 V. cholerae O1-infected patients and in single serum samples from 20 healthy control subjects. The responses in these individuals to V. cholerae O1 strains were also determined. Significant elevations in the homologous antibody response were found only in the convalescent-phase sera from both groups of patients with cholera. These findings may explain the basis for the lack of heterologous protection between the two serogroups of V. cholerae. Healthy controls had higher background levels of vibriocidal antibody to V. cholerae O1 than to V. cholerae O139.

摘要

霍乱弧菌O139血清群,现在被认为是第二种能够引起流行性严重脱水型霍乱的病原体,它含有一种荚膜多糖,这使得它难以用于针对霍乱弧菌O1优化的传统杀弧菌抗体检测。在对检测程序进行修改后,该程序涉及使用特定的细菌菌株、降低细菌接种量以及增加补体用量,对33例感染霍乱弧菌O139和18例感染霍乱弧菌O1的患者的急性期和恢复期血清以及20名健康对照者的单次血清样本中针对霍乱弧菌O139的杀弧菌抗体反应进行了测定。还测定了这些个体对霍乱弧菌O1菌株的反应。仅在两组霍乱患者的恢复期血清中发现同源抗体反应显著升高。这些发现可能解释了霍乱弧菌两个血清群之间缺乏异源保护的原因。健康对照者对霍乱弧菌O1的杀弧菌抗体背景水平高于对霍乱弧菌O139的。

相似文献

1
Comparison of the vibriocidal antibody response in cholera due to Vibrio cholerae O139 Bengal with the response in cholera due to Vibrio cholerae O1.比较由霍乱弧菌O139孟加拉型引起的霍乱与由霍乱弧菌O1引起的霍乱中杀弧菌抗体反应。
Clin Diagn Lab Immunol. 1995 Nov;2(6):685-8. doi: 10.1128/cdli.2.6.685-688.1995.
2
Comparison of immune responses in patients infected with Vibrio cholerae O139 and O1.感染霍乱弧菌O139和O1患者的免疫反应比较。
Infect Immun. 1997 Sep;65(9):3571-6. doi: 10.1128/iai.65.9.3571-3576.1997.
3
Vibriocidal antibody responses in North American volunteers exposed to wild-type or vaccine Vibrio cholerae O139: specificity and relevance to immunity.北美接触野生型或霍乱弧菌O139疫苗的志愿者的杀霍乱弧菌抗体反应:特异性及与免疫的相关性
Clin Diagn Lab Immunol. 1997 May;4(3):264-9. doi: 10.1128/cdli.4.3.264-269.1997.
4
Robust gut associated vaccine-specific antibody-secreting cell responses are detected at the mucosal surface of Bangladeshi subjects after immunization with an oral killed bivalent V. cholerae O1/O139 whole cell cholera vaccine: comparison with other mucosal and systemic responses.在孟加拉国受试者口服灭活二价霍乱弧菌O1/O139全细胞霍乱疫苗免疫后,在其黏膜表面检测到强大的肠道相关疫苗特异性抗体分泌细胞反应:与其他黏膜和全身反应的比较。
Vaccine. 2009 Feb 25;27(9):1386-92. doi: 10.1016/j.vaccine.2008.12.041. Epub 2009 Jan 13.
5
Comparison of O-specific polysaccharide responses in patients following infection with O139 versus vaccination with a bivalent (O1/O139) oral killed cholera vaccine in Bangladesh.孟加拉国感染 O139 血清型与接种二价(O1/O139)口服霍乱死疫苗后患者 O 特异性多糖反应的比较。
mSphere. 2023 Oct 24;8(5):e0025523. doi: 10.1128/msphere.00255-23. Epub 2023 Aug 30.
6
Serum antibacterial and antitoxin responses in clinical cholera caused by Vibrio cholerae O139 Bengal and evaluation of their importance in protection.由O139群霍乱弧菌引起的临床霍乱中的血清抗菌和抗毒素反应及其在保护作用中的重要性评估
Vaccine. 1996 Aug;14(12):1137-42. doi: 10.1016/0264-410x(96)00035-7.
7
Defining Polysaccharide-Specific Antibody Targets against Vibrio cholerae O139 in Humans following O139 Cholera and following Vaccination with a Commercial Bivalent Oral Cholera Vaccine, and Evaluation of Conjugate Vaccines Targeting O139.在感染 O139 霍乱弧菌和接种商业双价口服霍乱疫苗后,针对人类 O139 霍乱弧菌的多糖特异性抗体靶点的定义,以及针对 O139 的结合疫苗的评估。
mSphere. 2021 Aug 25;6(4):e0011421. doi: 10.1128/mSphere.00114-21. Epub 2021 Jul 7.
8
IgM specific to lipopolysaccharide of Vibrio cholerae is a surrogate antibody isotype responsible for serum vibriocidal activity.针对霍乱弧菌脂多糖的 IgM 是一种替代抗体同种型,负责血清杀弧菌活性。
PLoS One. 2019 Mar 7;14(3):e0213507. doi: 10.1371/journal.pone.0213507. eCollection 2019.
9
Reduction in capsular content and enhanced bacterial susceptibility to serum killing of Vibrio cholerae O139 associated with the 2002 cholera epidemic in Bangladesh.与2002年孟加拉国霍乱疫情相关的霍乱弧菌O139荚膜成分减少及对血清杀菌作用的细菌敏感性增强。
Infect Immun. 2005 Oct;73(10):6577-83. doi: 10.1128/IAI.73.10.6577-6583.2005.
10
Vibrio cholerae O139 conjugate vaccines: synthesis and immunogenicity of V. cholerae O139 capsular polysaccharide conjugates with recombinant diphtheria toxin mutant in mice.霍乱弧菌O139结合疫苗:霍乱弧菌O139荚膜多糖与重组白喉毒素突变体在小鼠体内的合成及免疫原性
Infect Immun. 2000 Sep;68(9):5037-43. doi: 10.1128/IAI.68.9.5037-5043.2000.

引用本文的文献

1
Seroconversion and Kinetics of Vibriocidal Antibodies during the First 90 Days of Re-Vaccination with Oral Cholera Vaccine in an Endemic Population.在地方性流行人群中口服霍乱疫苗再次接种的前90天内杀弧菌抗体的血清转化及动力学
Vaccines (Basel). 2024 Apr 8;12(4):390. doi: 10.3390/vaccines12040390.
2
Cholera toxin and O-specific polysaccharide immune responses after oral cholera vaccination with Dukoral in different age groups of Bangladeshi participants.口服 Dukoral 霍乱疫苗后不同年龄组孟加拉参与者的霍乱毒素和 O 特异性多糖免疫应答。
mSphere. 2024 Mar 26;9(3):e0056523. doi: 10.1128/msphere.00565-23. Epub 2024 Feb 23.
3
Clinical surveillance systems obscure the true cholera infection burden in an endemic region.临床监测系统掩盖了流行地区霍乱感染的真实负担。
Nat Med. 2024 Mar;30(3):888-895. doi: 10.1038/s41591-024-02810-4. Epub 2024 Feb 20.
4
Assessment of the influence of ABO blood groups on oral cholera vaccine immunogenicity in a cholera endemic area in Zambia.评估 ABO 血型对赞比亚霍乱流行地区口服霍乱疫苗免疫原性的影响。
BMC Public Health. 2023 Jan 23;23(1):152. doi: 10.1186/s12889-023-15051-w.
5
A subset of follicular helper-like MAIT cells can provide B cell help and support antibody production in the mucosa.滤泡辅助样 MAIT 细胞的一个亚群可以在黏膜中提供 B 细胞辅助并支持抗体产生。
Sci Immunol. 2022 Jan 14;7(67):eabe8931. doi: 10.1126/sciimmunol.abe8931.
6
Effect of HIV status and retinol on immunogenicity to oral cholera vaccine in adult population living in an endemic area of Lukanga Swamps, Zambia.在赞比亚卢坎加沼泽地流行区成年人群中,HIV感染状况和视黄醇对口服霍乱疫苗免疫原性的影响。
PLoS One. 2021 Dec 2;16(12):e0260552. doi: 10.1371/journal.pone.0260552. eCollection 2021.
7
Systemic, Mucosal, and Memory Immune Responses following Cholera.霍乱后的全身、黏膜和记忆免疫反应
Trop Med Infect Dis. 2021 Oct 27;6(4):192. doi: 10.3390/tropicalmed6040192.
8
Defining Polysaccharide-Specific Antibody Targets against Vibrio cholerae O139 in Humans following O139 Cholera and following Vaccination with a Commercial Bivalent Oral Cholera Vaccine, and Evaluation of Conjugate Vaccines Targeting O139.在感染 O139 霍乱弧菌和接种商业双价口服霍乱疫苗后,针对人类 O139 霍乱弧菌的多糖特异性抗体靶点的定义,以及针对 O139 的结合疫苗的评估。
mSphere. 2021 Aug 25;6(4):e0011421. doi: 10.1128/mSphere.00114-21. Epub 2021 Jul 7.
9
Vibrio cholerae Sialidase-Specific Immune Responses Are Associated with Protection against Cholera.霍乱弧菌唾液酸酶特异性免疫应答与霍乱保护作用相关。
mSphere. 2021 Apr 28;6(2):e01232-20. doi: 10.1128/mSphere.01232-20.
10
Immunogenicity of a killed bivalent whole cell oral cholera vaccine in forcibly displaced Myanmar nationals in Cox's Bazar, Bangladesh.孟加拉国考克斯巴扎尔地区强制流离失所的缅甸国民中,二价全细胞口服霍乱疫苗的免疫原性。
PLoS Negl Trop Dis. 2020 Mar 16;14(3):e0007989. doi: 10.1371/journal.pntd.0007989. eCollection 2020 Mar.

本文引用的文献

1
Lack of cross-protection against diarrhea due to Vibrio cholerae O139 (Bengal strain) after oral immunization of rabbits with V. cholerae O1 vaccine strain CVD103-HgR.用霍乱弧菌O1疫苗株CVD103-HgR对兔进行口服免疫后,缺乏针对霍乱弧菌O139(孟加拉菌株)所致腹泻的交叉保护作用。
J Infect Dis. 1994 Jan;169(1):230-1. doi: 10.1093/infdis/169.1.230.
2
Vibrio cholerae O139 synonym bengal is closely related to Vibrio cholerae El Tor but has important differences.霍乱弧菌O139(同义词:孟加拉型)与埃尔托霍乱弧菌密切相关,但存在重要差异。
Infect Immun. 1994 May;62(5):2108-10. doi: 10.1128/iai.62.5.2108-2110.1994.
3
Lack of cross-protection against diarrhea due to Vibrio cholerae O1 after oral immunization of rabbits with V. cholerae O139 Bengal.用霍乱弧菌O139孟加拉株对家兔进行口服免疫后,缺乏针对霍乱弧菌O1血清群所致腹泻的交叉保护作用。
J Infect Dis. 1994 Mar;169(3):709-10. doi: 10.1093/infdis/169.3.709.
4
Vibrio cholerae non-O1--the eighth pandemic?非O1群霍乱弧菌——第八次大流行?
Lancet. 1993 Aug 14;342(8868):382-3. doi: 10.1016/0140-6736(93)92806-5.
5
Large outbreak of clinical cholera due to Vibrio cholerae non-O1 in Bangladesh.孟加拉国因非O1群霍乱弧菌引发的临床霍乱大规模暴发。
Lancet. 1993 Mar 13;341(8846):704. doi: 10.1016/0140-6736(93)90481-u.
6
Vibrio cholerae O139 Bengal possesses a capsular polysaccharide which may confer increased virulence.霍乱弧菌O139孟加拉菌株拥有一种荚膜多糖,它可能会增强毒力。
Microb Pathog. 1994 Mar;16(3):235-41. doi: 10.1006/mpat.1994.1024.
7
Vibrio cholerae non-O1 serogroup associated with cholera gravis genetically and physiologically resembles O1 E1 Tor cholera strains.与重症霍乱相关的非O1血清群霍乱弧菌在遗传和生理上类似于O1埃托型霍乱菌株。
Infect Immun. 1994 Sep;62(9):3859-63. doi: 10.1128/iai.62.9.3859-3863.1994.
8
The Vibrio cholerae O139 serogroup antigen includes an O-antigen capsule and lipopolysaccharide virulence determinants.霍乱弧菌O139血清群抗原包括O抗原荚膜和脂多糖毒力决定簇。
Proc Natl Acad Sci U S A. 1994 Nov 22;91(24):11388-92. doi: 10.1073/pnas.91.24.11388.
9
Vibrio cholerae O139 Bengal.霍乱弧菌O139孟加拉型
J Clin Microbiol. 1994 Oct;32(10):2345-9. doi: 10.1128/jcm.32.10.2345-2349.1994.
10
Clinical and immunologic characteristics of Vibrio cholerae O139 Bengal infection in North American volunteers.北美志愿者中霍乱弧菌O139孟加拉感染的临床和免疫学特征
J Infect Dis. 1995 Apr;171(4):903-8. doi: 10.1093/infdis/171.4.903.